Pulsed dye laser: what's new in non-vascular lesions?
OBJECTIVE
In dermatology, the pulsed dye laser (PDL) is the therapeutic instrument of choice for treating most superficial cutaneous vascular lesions. In addition, clinical experience over the last decade allowed us to treat patients with an ever increasing number of non-vascular indications. The purpose of this report is to summarize and critically appraise the scientific evidence that support the role of PDL in treating non-vascular skin lesions.


METHODS
A literature-based study has been conducted, including the review of publications over the period January 1995 to December 2006, using the Medline Database. We also included our own experience in managing non-vascular lesions with the PDL. Four sets of preoperative and postoperative photos are presented.


RESULTS
For viral skin lesions, PDL proved to be an alternative to other therapy options. This applies particularly to periungual warts and mollusca contagiosa. The mechanism of PDL with inflammatory dermatoses has not yet been elucidated. The effect seems to be better if there is a vascular component to the disease. With most of these indications (such as psoriasis and acne), PDL currently plays a rather minor or complementary role. Regarding collagen remodelling (hypertrophic scars, keloids, stretch marks, and skin rejuvenation), the question of whether a therapy makes sense or not has to be decided from case to case.


CONCLUSIONS
With PDL, it is possible to achieve good results with numerous, partly less well-known indications (i.e. lupus erythematosus). With other diseases, PDL has so far been considered to be a complementary therapy method or to be in an experimental state.
Laserklinik Karlsruhe, Karlsruhe, Germany. syruskarsai@aol.com
S
S
Karsai
S
S
Roos
S
S
Hammes
C
C
Raulin
D003880:Dermatology / Q000295:instrumentation*; D006801:Humans; D028022:Low-Level Light Therapy / Q000009:adverse effects / Q000379:methods*; D012871:Skin Diseases / Q000532:radiotherapy*